Ximluci
Solution for injection
Compare
|
EU/1/22/1691/001
Authorised: 09/11/2022
Stada Arzneimittel AG
|
SPC
PIL
IPAR
|
Ximluci
Solution for injection
Compare
|
EU/1/22/1691/002
Authorised: 09/11/2022
Stada Arzneimittel AG
|
SPC
PIL
IPAR
|
Xofigo
Solution for injection
Compare
|
EU/1/13/873/001
Authorised: 13/11/2013
Bayer AG
|
SPC
PIL
IPAR
|
Xofluza
Film-coated tablet
Compare
|
EU/1/20/1500/001
Authorised: 07/01/2021
Roche Registration GmbH
|
SPC
PIL
IPAR
|
Xofluza
Film-coated tablet
Compare
|
EU/1/20/1500/002
Authorised: 07/01/2021
Roche Registration GmbH
|
SPC
PIL
IPAR
|
Xofluza
Film-coated tablet
Compare
|
EU/1/20/1500/003
Authorised: 07/01/2021
Roche Registration GmbH
|
SPC
PIL
IPAR
|
Xofluza
Granules for oral suspension
Compare
|
EU/1/20/1500/005
Authorised: 07/01/2021
Roche Registration GmbH
|
SPC
PIL
IPAR
|
Xolair
Powder and solvent for solution for injection
Compare
|
EU/1/05/319/001
Authorised: 25/10/2005
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Xolair
Powder and solvent for solution for injection
Compare
|
EU/1/05/319/002
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Xolair
Solution for injection in pre-filled syringe
Compare
|
EU/1/05/319/012-014
Authorised: 06/11/2023
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Xolair
Solution for injection in pre-filled pen
Compare
|
EU/1/05/319/015-017
Authorised: 06/11/2023
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Xolair
Solution for injection in pre-filled syringe
Compare
|
EU/1/05/319/5-7
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Xolair 150 mg solution for injection in pre-filled syringe
Solution for injection in pre-filled syringe
Compare
|
EU/1/05/319/8-10
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Xonvea 10 mg/10 mg gastro-resistant tablets
Gastro-resistant tablet
Compare
|
PA22998/006/001
Authorised: 05/04/2019
Exeltis healthcare S.L.
|
SPC
PIL
IPAR
|
Xonvea MR 20 mg/20 mg modified-release tablets
Modified-release tablet
Compare
|
PA22998/003/001
Authorised: 30/06/2023
Exeltis healthcare S.L.
|
SPC
PIL
IPAR
|
XOSPATA
Film-coated tablet
Compare
|
EU/1/19/1399/001
Authorised: 24/10/2019
Astellas Pharma Europe B.V.
|
SPC
PIL
IPAR
EdM
|
Xoterna Breezhaler
Inhalation powder, hard capsule
Compare
|
EU/1/13/863/001-006
Authorised: 19/09/2013
Novartis Europharm Limited
|
SPC
PIL
IPAR
|
Xromi
Oral solution
Compare
|
EU/1/19/1366/001
Authorised: 01/07/2019
Nova Laboratories Ireland Limited
|
SPC
PIL
IPAR
EdM
|
Xtandi
Capsule, soft
Compare
|
EU/1/13/846/001
Astellas Pharma Europe BV
|
SPC
PIL
IPAR
|
Xtandi
Film-coated tablet
Compare
|
EU/1/13/846/002
Authorised: 21/09/2017
Astellas Pharma Europe B.V.
|
SPC
PIL
IPAR
|